1. Home
  2. GKOS vs IBCP Comparison

GKOS vs IBCP Comparison

Compare GKOS & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • IBCP
  • Stock Information
  • Founded
  • GKOS 1998
  • IBCP 1864
  • Country
  • GKOS United States
  • IBCP United States
  • Employees
  • GKOS N/A
  • IBCP N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • IBCP Major Banks
  • Sector
  • GKOS Health Care
  • IBCP Finance
  • Exchange
  • GKOS Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • GKOS 5.1B
  • IBCP 630.0M
  • IPO Year
  • GKOS 2015
  • IBCP N/A
  • Fundamental
  • Price
  • GKOS $90.26
  • IBCP $30.12
  • Analyst Decision
  • GKOS Strong Buy
  • IBCP Hold
  • Analyst Count
  • GKOS 13
  • IBCP 3
  • Target Price
  • GKOS $155.00
  • IBCP $39.17
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • IBCP 128.3K
  • Earning Date
  • GKOS 04-30-2025
  • IBCP 04-24-2025
  • Dividend Yield
  • GKOS N/A
  • IBCP 3.46%
  • EPS Growth
  • GKOS N/A
  • IBCP 13.26
  • EPS
  • GKOS N/A
  • IBCP 3.16
  • Revenue
  • GKOS $383,481,000.00
  • IBCP $218,142,000.00
  • Revenue This Year
  • GKOS $27.84
  • IBCP N/A
  • Revenue Next Year
  • GKOS $27.99
  • IBCP $6.51
  • P/E Ratio
  • GKOS N/A
  • IBCP $9.53
  • Revenue Growth
  • GKOS 21.85
  • IBCP 8.64
  • 52 Week Low
  • GKOS $77.91
  • IBCP $22.53
  • 52 Week High
  • GKOS $163.71
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 41.57
  • IBCP 48.39
  • Support Level
  • GKOS $86.16
  • IBCP $28.05
  • Resistance Level
  • GKOS $94.55
  • IBCP $30.84
  • Average True Range (ATR)
  • GKOS 6.54
  • IBCP 1.28
  • MACD
  • GKOS 1.11
  • IBCP 0.18
  • Stochastic Oscillator
  • GKOS 54.51
  • IBCP 74.07

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: